Thank you for your visits at RICAI on december 13th and 14th 2021
Thank you all for your visits and your encouragements! We came back confident and more motivated in our access to the market!
Dendris at RICAI on december 13th and 14th 2021 (Stand 35)
Dendris will be present at the RICAI at "Palais des Congrès" in Paris on December 13 and 14, 2021 Interdisciplinary Meeting of Anti-Infectious Chemotherapy 41st edition of the RICAI with a very varied program this year while emphasizing diagnostic and therapeutic...
Initiated at the end of 2020, the automation of DendrisChip technology in microplate format is born! Performed on Hamilton platform, the automated solution can test up to 96 samples simultaneously, from PCR product purification to reading, in 3 hours.
Dendris automates its process on the HAMILTON platform
Started in 2020, the development of the automated version of hybridization steps will be completed in 2021 in partnership with Hamilton. The automation of our solution is one of the priority points to fully meet the productivity needs of our testing laboratories. This...
ISO 13485 certification brilliantly obtained
The British organization BSI reiterates the certification of Dendris with only two minor deviations noted during its renewal audit in October 2020. ISO 13485 specific to medical devices.
Dendris supported by the region and Bpifrance for the automation of its solution.
New financing granted to Dendris in order to continue its development plan. "I am pleased to inform you of the agreement to support your company in its projects through a refundable advance of 207,000 euros, respectively financed by the Ministry of the Economy and...
In 2019, Dendris signs a partnership with LALLEMAND / UMR for the development of a biochip for diagnosis of ruminal fibrolytic activity.
Lallemand, world leader in the development, production and sale of yeasts, bacteria and derived ingredients, associated with UMR MEDIS (Digestive environment and health microbiology dependent on Inra and university) asked Dendris to develop a biochip for studying the...
Dendris receives award for excellence at European research and innovation program Horizon 2020
Dendris Gendiag project « Next GENeration of inn vitro DIAGnostic in clinical microbiology » was assessed as a high quality project.